These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16888631)

  • 1. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations.
    Bauer J; Curtin JA; Pinkel D; Bastian BC
    J Invest Dermatol; 2007 Jan; 127(1):179-82. PubMed ID: 16888631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
    Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
    Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population.
    Wu D; Wang M; Wang X; Yin N; Song T; Li H; Yu J; Wang DM; Zhao Z
    Am J Dermatopathol; 2011 Jun; 33(4):341-4. PubMed ID: 21430505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.
    Karram S; Novy M; Saroufim M; Loya A; Taraif S; Houreih MA; Rauscher B; Habib RH; Oberkanins C; Khalifeh I
    Am J Dermatopathol; 2013 Jun; 35(4):412-8. PubMed ID: 23051629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.
    Thomas NE; Edmiston SN; Alexander A; Millikan RC; Groben PA; Hao H; Tolbert D; Berwick M; Busam K; Begg CB; Mattingly D; Ollila DW; Tse CK; Hummer A; Lee-Taylor J; Conway K
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):991-7. PubMed ID: 17507627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi.
    Francis JH; Grossniklaus HE; Habib LA; Marr B; Abramson DH; Busam KJ
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):117-121. PubMed ID: 29332123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi.
    Dessars B; De Raeve LE; El Housni H; Debouck CJ; Sidon PJ; Morandini R; Roseeuw D; Ghanem GE; Vassart G; Heimann P
    J Invest Dermatol; 2007 Jun; 127(6):1468-70. PubMed ID: 17301836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases.
    Phadke PA; Rakheja D; Le LP; Selim MA; Kapur P; Davis A; Mihm MC; Hoang MP
    Am J Surg Pathol; 2011 May; 35(5):656-69. PubMed ID: 21436676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
    Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
    Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi.
    Charbel C; Fontaine RH; Malouf GG; Picard A; Kadlub N; El-Murr N; How-Kit A; Su X; Coulomb-L'Hermine A; Tost J; Mourah S; Aractingi S; Guégan S
    J Invest Dermatol; 2014 Apr; 134(4):1067-1074. PubMed ID: 24129063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
    Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ
    J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF mutations are common somatic events in melanocytic nevi.
    Kumar R; Angelini S; Snellman E; Hemminki K
    J Invest Dermatol; 2004 Feb; 122(2):342-8. PubMed ID: 15009715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
    de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
    Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi.
    Ichii-Nakato N; Takata M; Takayanagi S; Takashima S; Lin J; Murata H; Fujimoto A; Hatta N; Saida T
    J Invest Dermatol; 2006 Sep; 126(9):2111-8. PubMed ID: 16691193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis.
    Wu J; Rosenbaum E; Begum S; Westra WH
    Am J Dermatopathol; 2007 Dec; 29(6):534-7. PubMed ID: 18032947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.
    Tschandl P; Berghoff AS; Preusser M; Burgstaller-Muehlbacher S; Pehamberger H; Okamoto I; Kittler H
    PLoS One; 2013; 8(7):e69639. PubMed ID: 23861977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract.
    Tseng D; Kim J; Warrick A; Nelson D; Pukay M; Beadling C; Heinrich M; Selim MA; Corless CL; Nelson K
    J Am Acad Dermatol; 2014 Aug; 71(2):229-36. PubMed ID: 24842760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations in melanocytic tumors.
    Takata M; Saida T
    J Dermatol Sci; 2006 Jul; 43(1):1-10. PubMed ID: 16750612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.
    Akslen LA; Puntervoll H; Bachmann IM; Straume O; Vuhahula E; Kumar R; Molven A
    Melanoma Res; 2008 Feb; 18(1):29-35. PubMed ID: 18227705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.